Maju Mathews, MD
- 12Articles
- 63.9KReads
- 2006–2017Active
- 29Collaborators
- 116Citations
About
Maju Mathews, MD, has published extensively on psychiatric conditions including schizophrenia, schizoaffective disorders, anxiety, bipolar disorder, and major depressive disorder. The author’s work covers clinical topics such as the use and safety of anxiolytics and antidepressants like vilazodone and fluoxetine, as well as adverse effects related to neuroleptic medications. Mathews has also contributed to research on neuropsychiatric phenomena including neuroleptic malignant syndrome and the neurological aspects of Parkinson disease. Publications span from 2006 to 2017 in Psychiatrist.com journals.
Publications
A Case of Caffeine Intolerance With Long-Term Use of Fluoxetine
June 1, 2017
Clinical Relevance of Vilazodone Treatment in Patients With Major Depressive Disorder: Categorical Improvement in Symptoms
January 30, 2014
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
